CDKN3 and neuroblastoma: To examine the clinical relevance of elevated CDKN3 expression in neuroblastoma, we investigated the correlation of CDKN3 mRNA levels in neuroblastoma tumor specimens with patient survival based on three public patient datasets in the R2 Genomics platform.